A monoclonal antibody called trastuzumab specifically targets the HER2 protein that is present on the surface of cancer cells. It is frequently applied to the management of HER2-positive gastric and breast cancer. By inhibiting the HER2 protein, trastuzumab slows the development and spread of cancer cells. Healthcare personnel often administer the injection intravenously. With HER2-positive malignancies, trastuzumab has demonstrated efficacy in enhancing outcomes and survival rates. Oncologists with experience should be in charge of monitoring its use because it might have potential negative effects. Consult a healthcare professional for the most up-to-date information.
1. Trasturel, a monoclonal antibody and a form of targeted therapy, specifically targets the HER2 protein that is present on the surface of cancer cells.
2. Treatment for HER2-Positive Cancer: Trasturel is recommended especially for the management of HER2-positive breast cancer and HER2-positive gastric cancer.
3. Trasturel is frequently given by healthcare professionals as an intravenous infusion, which ensures accurate dosing and monitoring.
1. HER2-positive cancer cells' development and metastasis are slowed down by Trasturel's targeted therapy, which works to specifically block the HER2 protein.
2. Improved Results: In patients with HER2-positive malignancies, trasturel has been demonstrated to be helpful in extending overall survival and progression-free survival.
3. Trasturel can be used to treat HER2-positive breast cancer in both adjuvant (post-surgery) and neoadjuvant (pre-surgery) settings, lowering the chance of cancer recurrence.
4. Combination Therapy: To increase the effectiveness of Trasturel in the treatment of HER2-positive cancer, it is frequently used in conjunction with other cancer drugs.
5. Potential for Less Severe Side Effects: For certain patients, targeted therapy like Trasturel may result in less severe side effects than conventional chemotherapy.
Individual responses to treatment may differ from person to person, thus any side effects should be explored with a healthcare professional. Use of Trasturel (trastuzumab injection) must be supervised by a qualified medical professional. Consult a healthcare professional or refer to up-to-date medical sources for the most recent information.
Trasturel is a drug used to treat certain cancer types, such as:
1. Breast cancer with HER2 positivity: Trasturel is recommended for the treatment of HER2-positive breast cancer. Both early-stage and advanced-stage breast cancers are treated with it.
2. HER2-Positive Stomach (Gastric) Cancer: Trasturel is also used in conjunction with other cancer treatments to treat stomach (gastric) cancer that is HER2-positive.
Trasturel inhibits the proliferation and spread of cancer cells by specifically targeting the HER2 protein that is present on their surface.
1. Infusion Reactions: Immediate or delayed reactions during or after the infusion, such as fever, chills, nausea, and rash.
4. Nausea and Vomiting
5. Decreased White Blood Cell Counts (Neutropenia)
7. Muscle Pain
9. Shortness of Breath
Rare but severe side effects like heart and lung issues can happen. Trasturel may also make some infections more likely.
Before beginning Trasturel medication, it's crucial to go over potential side effects and advantages with a healthcare professional. To manage and reduce side effects, medical personnel will continuously monitor patients during therapy. Consult a healthcare professional or refer to up-to-date medical sources for the most recent information.